Drug record
What four public record sets show for citalopram. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.029 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $51.2 million | Details |
| FDA recall records | 8 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Citalopram Hbr 10 Mg Tablet: pharmacies pay about $0.029 each, or $0.857 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| CITALOPRAM HBR 10 MG TABLET | Generic | $0.029 per each | $0.857 | Oct 21, 2026 |
| CITALOPRAM HBR 10 MG/5 ML SOLN | Generic | $0.193 per mL | — | Oct 21, 2026 |
| CITALOPRAM HBR 20 MG TABLET | Generic | $0.030 per each | $0.909 | Oct 21, 2026 |
| CITALOPRAM HBR 30 MG CAPSULE | Generic | $4.74 per each | $142.06 | Oct 21, 2026 |
| CITALOPRAM HBR 40 MG TABLET | Generic | $0.042 per each | $1.25 | Oct 21, 2026 |
| CELEXA 20 MG TABLET | Brand | $9.04 per each | $271.20 | Oct 21, 2026 |
| CELEXA 40 MG TABLET | Brand | $9.47 per each | $284.07 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $51.2 million for the 2 products below. That is down 21% from $65.0 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Citalopram HBr Citalopram Hydrobromide | $48.6 million | 1,421,995 | $7.21 | $34.18 | $61.5 million |
| Celexa Citalopram Hydrobromide | $2.6 million | 949 | $609.41 | $2,694.52 | $3.5 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 8 recall records that name citalopram in the product description (7 Class II · 1 Class III).
CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 0378-6232-01
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40
Reason: Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint
All citalopram Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.
Reason: Lack of Processing Controls
Citalopram Hydrobromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
CITALOPRAM Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 57664050788
Reason: Labeling:Label Mixup; CITALOPRAM Tablet, 10 mg may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: AD52778_61, EXP: 5/20/2014; COENZYME Q-10, Capsule, 30 mg, NDC 00904501546, Pedigree: W002814, EXP: 6/7/2014.
Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-344-30
Reason: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Citalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-342-30
Reason: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
Reason: Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for citalopram. This page is public-record information, not medical advice.